Novel Oral Polio Vaccine Type 1 (nOPV1)

BIOLOGICAL2 trials

Sponsors

PATH

Conditions

Poliomyelitis

Phase 1

Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines

CompletedNCT04529538

PATHPoliomyelitis

Start: 2021-03-26End: 2023-02-17Updated: 2024-11-20

Phase 2

Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation

RecruitingNCT06895486

PATHPoliomyelitis

Start: 2025-11-11End: 2026-12-28Target: 675Updated: 2026-01-09

Related Papers

Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial.

2025-08-131 citations

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.

2020-12-0944 citations